Literature DB >> 25833513

Open questions concerning taurine with emphasis on the brain.

Simo S Oja1, Pirjo Saransaari.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25833513     DOI： 10.1007/978-3-319-15126-7_31

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Multicompartment analysis of protein-restricted phenylketonuric mice reveals amino acid imbalances in brain.

Authors:  Kara R Vogel; Erland Arning; Teodoro Bottiglieri; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2016-10-19       Impact factor: 4.982

2.  The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation.

Authors:  Neveen Madbouly; Ayman Azmy; Abeer Salama; Azza El-Amir
Journal:  J Antibiot (Tokyo)       Date:  2021-07-12       Impact factor: 2.649

Review 3.  Taurine as an Essential Neuromodulator during Perinatal Cortical Development.

Authors:  Werner Kilb; Atsuo Fukuda
Journal:  Front Cell Neurosci       Date:  2017-10-24       Impact factor: 5.505

Review 4.  Effects of the Usage of l-Cysteine (l-Cys) on Human Health.

Authors:  Noelia Clemente Plaza; Manuel Reig García-Galbis; Rosa María Martínez-Espinosa
Journal:  Molecules       Date:  2018-03-03       Impact factor: 4.411

5.  Taurine supplementation abates cirrhosis-associated locomotor dysfunction.

Authors:  Reza Heidari; Akram Jamshidzadeh; Vahid Ghanbarinejad; Mohammad Mehdi Ommati; Hossein Niknahad
Journal:  Clin Exp Hepatol       Date:  2018-05-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.